Neoadjuvant chemotherapy in high-risk soft tissue sarcomas: A Sarculator-based risk stratification analysis of the ISG-STS 1001 randomized trial.

Fecha de publicación: Fecha Ahead of Print:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Pasquali, Sandro
  • Palmerini, Emanuela
  • Quagliuolo, Vittorio
  • Martin-Broto, Javier
  • Lopez-Pousa, Antonio
  • Grignani, Giovanni
  • Brunello, Antonella
  • Blay, Jean-Yves
  • Tendero, Oscar
  • Ferraresi, Virginia
  • Lugowska, Iwona
  • Infante, Gabriele
  • Braglia, Luca
  • Merlo, Domenico Franco
  • Fontana, Valeria
  • Marchesi, Emanuela
  • Donati, Davide Maria
  • Palassini, Elena
  • Bianchi, Giuseppe
  • Marrari, Andrea
  • Morosi, Carlo
  • Stacchiotti, Silvia
  • Bague, Silvia
  • Coindre, Jean Michel
  • Dei Tos, Angelo Paolo
  • Picci, Piero
  • Bruzzi, Paolo
  • Miceli, Rosalba
  • Casali, Paolo Giovanni
  • Gronchi, Alessandro

Grupos

Abstract

The value of neoadjuvant chemotherapy in soft tissue sarcoma (STS) is not completely understood. This study investigated the benefit of neoadjuvant chemotherapy according to prognostic stratification based on the Sarculator nomogram for STS.

© 2021 American Cancer Society.

Datos de la publicación

ISSN/ISSNe:
0008-543X, 1097-0142

CANCER  WILEY

Tipo:
Article
Páginas:
85-93
PubMed:
34643947
Enlace a otro recurso:
www.scopus.com
Factor de Impacto:
2,463 SCImago ℠
Cuartil:
Q1 SCImago ℠

Citas Recibidas en Web of Science: 96

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • chemotherapy, clinical trial, neoadjuvant, nomogram, sarcoma

Campos de Estudio

Cita

Compartir